Skip to main content

Table 2 A list of estimated critical dose rate, \(R_{{{\text{critic}}}}\) and time, \(T_{{{\text{critic}}}}\)

From: Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters

Cancer type \(R_{{{\text{critic}}}}\)(Gy/days) \(R_{{{\text{critic}}\left( k \right)}}\)(Gy/days) \(R_{0}\)(Gy/days) \(T_{{{\text{critic}}}}\)(days)
Breast 0.620 3.32 12.3 12
PNET 0.465 3.45 13.1 13
Adrenocortical carcinoma 1.0 16.3 13.5 10
CRC 0.814 5.24 32.8 14
Cholangiocarcinoma 0.231 1.13 7.28 13
CRC 1.0 56.1 8.62 8
CRC 0.481 3.01 11.0 12
Rectal adenocarcinoma 0.012 0.13 3.18 22
Cholangiocarcinoma 0.02 0.14 8.82 23
CRC 0.777 6.76 8.59 9
Cholangiocarcinoma 11.7 693 70.5 7
Cholangiocarcinoma 0.041 0.60 10.2 21
Sigmoid adenocarcinoma 0.015 0.13 13.0 26
Breast 0.048 0.16 11.8 21
Prostate 0.028 0.12 8.65 22
mCRC 0.238 0.46 7.65 13
PNET 5.00 × 10−3 0.01 11.0 30
PDAC 0.013 0.05 2.29 20
SBNET 0.003 0.02 59.8 38
Mesothelioma 0.442 1.76 15.5 14
PNET 0.028 0.12 25.4 26
HCC 3.070 26.5 20.9 7
Oesophageal 0.069 0.30 4.58 16
SBNET 0.362 2.36 12.9 14
NEC 0.284 22.4 4.44 11
  1. \(R_{{{\text{critic}}}}\), critical dose rate; \(R_{{{\text{critic}}\left( k \right)}}\), critical dose rate considering the \(T_{{\text{k}}}\); \(R_{0}\), initial dose rate; \(T_{{{\text{critic}}}}\), critical time.